AR095220A1 - Conjunto para un dispositivo de administración de fármacos - Google Patents

Conjunto para un dispositivo de administración de fármacos

Info

Publication number
AR095220A1
AR095220A1 ARP140100829A ARP140100829A AR095220A1 AR 095220 A1 AR095220 A1 AR 095220A1 AR P140100829 A ARP140100829 A AR P140100829A AR P140100829 A ARP140100829 A AR P140100829A AR 095220 A1 AR095220 A1 AR 095220A1
Authority
AR
Argentina
Prior art keywords
drug
movement
assembly
dose
actuator
Prior art date
Application number
ARP140100829A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR095220A1 publication Critical patent/AR095220A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
    • A61M5/31541—Means preventing setting of a dose beyond the amount remaining in the cartridge
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/31555—Mechanically operated dose setting member by purely axial movement of dose setting member, e.g. during setting or filling of a syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
    • A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
    • A61M5/31585—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod performed by axially moving actuator, e.g. an injection button
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Se proporciona un conjunto (30) para un dispositivo (1) de administración de fármacos, en el que el conjunto (30) comprende un actuador (16) que está configurado para realizar un movimiento de establecimiento en una dirección proximal con el fin de establecer una dosis de un fármaco, y que está configurado para realizar un movimiento de administración en una dirección distal con el fin de administrar una dosis de un fármaco. El conjunto (30) comprende además un mecanismo (40) de tope que actúa después de que una cantidad máxima de un fármaco ha sido administrada, que está configurado para limitar axialmente el movimiento de establecimiento del actuador (16) de manera que se inhibe el establecimiento de una dosis, en el que se permite un movimiento axial limitado del actuador (16).
ARP140100829A 2013-03-11 2014-03-11 Conjunto para un dispositivo de administración de fármacos AR095220A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13158511 2013-03-11

Publications (1)

Publication Number Publication Date
AR095220A1 true AR095220A1 (es) 2015-09-30

Family

ID=47845804

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100829A AR095220A1 (es) 2013-03-11 2014-03-11 Conjunto para un dispositivo de administración de fármacos

Country Status (15)

Country Link
US (1) US10117998B2 (es)
EP (1) EP2968780B1 (es)
JP (1) JP6386481B2 (es)
KR (1) KR20150126929A (es)
CN (1) CN105025964B (es)
AR (1) AR095220A1 (es)
AU (1) AU2014231035B2 (es)
BR (1) BR112015021333A2 (es)
DK (1) DK2968780T3 (es)
HK (1) HK1213512A1 (es)
IL (1) IL240547A0 (es)
MX (1) MX2015012118A (es)
RU (1) RU2015142824A (es)
TW (1) TW201507749A (es)
WO (1) WO2014139909A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6479795B2 (ja) * 2013-11-22 2019-03-06 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 薬物送達デバイス
EP3181171A1 (en) 2015-12-14 2017-06-21 Sanofi-Aventis Deutschland GmbH Drive mechanism for an injection device
EP3181169A1 (en) * 2015-12-14 2017-06-21 Sanofi-Aventis Deutschland GmbH Drive mechanism for an injection device
US10369292B2 (en) * 2016-01-15 2019-08-06 W. L. Gore & Associates, Inc. Syringe plunger assemblies
CN109952121B (zh) * 2016-07-01 2021-08-10 赛诺菲 药物输送装置

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US533575A (en) 1895-02-05 wilkens
US5226895A (en) 1989-06-05 1993-07-13 Eli Lilly And Company Multiple dose injection pen
GB9007113D0 (en) 1990-03-29 1990-05-30 Sams Bernard Dispensing device
DK0525525T3 (da) 1991-07-24 1995-10-02 Medico Dev Investment Co Injektor
DK175491D0 (da) 1991-10-18 1991-10-18 Novo Nordisk As Apparat
US5279586A (en) 1992-02-04 1994-01-18 Becton, Dickinson And Company Reusable medication delivery pen
US5320609A (en) 1992-12-07 1994-06-14 Habley Medical Technology Corporation Automatic pharmaceutical dispensing syringe
US5383865A (en) 1993-03-15 1995-01-24 Eli Lilly And Company Medication dispensing device
ZA941881B (en) 1993-04-02 1995-09-18 Lilly Co Eli Manifold medication injection apparatus and method
US5582598A (en) 1994-09-19 1996-12-10 Becton Dickinson And Company Medication delivery pen with variable increment dose scale
NZ302558A (en) 1995-03-07 1999-11-29 Lilly Co Eli Dispensing apparatus with a medication cartridge with a manually adjustable metering mechanism
US5688251A (en) 1995-09-19 1997-11-18 Becton Dickinson And Company Cartridge loading and priming mechanism for a pen injector
US5674204A (en) 1995-09-19 1997-10-07 Becton Dickinson And Company Medication delivery pen cap actuated dose delivery clutch
DE19730999C1 (de) 1997-07-18 1998-12-10 Disetronic Licensing Ag Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
US5957896A (en) 1997-08-11 1999-09-28 Becton, Dickinson And Company Medication delivery pen
ES2153711T3 (es) 1998-01-30 2001-03-01 Novo Nordisk As Jeringuilla de inyeccion.
US6096010A (en) 1998-02-20 2000-08-01 Becton, Dickinson And Company Repeat-dose medication delivery pen
US6221053B1 (en) 1998-02-20 2001-04-24 Becton, Dickinson And Company Multi-featured medication delivery pen
US6248095B1 (en) 1998-02-23 2001-06-19 Becton, Dickinson And Company Low-cost medication delivery pen
ES2258469T3 (es) 1999-08-05 2006-09-01 Becton Dickinson And Company Lapiz de administracion de medicacion.
DE60016271T2 (de) 1999-10-21 2005-12-01 Alcon Inc. Medikamentenzuführvorrichtung
GB0007071D0 (en) 2000-03-24 2000-05-17 Sams Bernard One-way clutch mechanisms and injector devices
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
US6899699B2 (en) 2001-01-05 2005-05-31 Novo Nordisk A/S Automatic injection device with reset feature
AU2002353761A1 (en) * 2001-03-27 2003-03-18 Eli Lilly And Company Medication dispensing apparatus configured for pull to set dose and push to inject set dose functionality
ES2400055T3 (es) 2001-05-16 2013-04-05 Eli Lilly And Company Aparato inyector de medicamentos
US20040236285A1 (en) * 2001-07-16 2004-11-25 Fisher Mark James Medication dispensing apparatus configured for rotate to prime and pull/push to inject functionality
GB0304823D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
GB0308267D0 (en) 2003-04-10 2003-05-14 Dca Design Int Ltd Improvements in and relating to a pen-type injector
DE102004063648A1 (de) 2004-12-31 2006-07-20 Tecpharma Licensing Ag Injektions- oder Infusionsgerät mit Lebensdauer-Ermittlungseinrichtung
EP1923085A1 (en) * 2006-11-17 2008-05-21 Sanofi-Aventis Deutschland GmbH Dosing and drive mechanism for drug delivery device
US8647309B2 (en) 2008-05-02 2014-02-11 Sanofi-Aventis Deutschland Gmbh Medication delivery device
AR078459A1 (es) * 2009-09-30 2011-11-09 Sanofi Aventis Deutschland Conjunto de accionamiento, vastago de piston, dispositivo para la entrega de drogas, y uso de un resorte
EP2329857A1 (en) 2009-12-03 2011-06-08 Sanofi-Aventis Deutschland GmbH A drug delivery device
AR083299A1 (es) * 2010-10-06 2013-02-13 Sanofi Aventis Deutschland Mecanismo de impulso para un dispositivo de administracion de farmacos y dispositivo de administracion de farmacos
EP2452710A1 (en) * 2010-11-12 2012-05-16 Sanofi-Aventis Deutschland GmbH Assembly for a drug delivery device and piston rod

Also Published As

Publication number Publication date
BR112015021333A2 (pt) 2017-07-18
EP2968780A1 (en) 2016-01-20
EP2968780B1 (en) 2019-09-18
WO2014139909A1 (en) 2014-09-18
AU2014231035A1 (en) 2015-09-24
HK1213512A1 (zh) 2016-07-08
AU2014231035B2 (en) 2018-07-05
DK2968780T3 (da) 2019-12-09
JP6386481B2 (ja) 2018-09-05
MX2015012118A (es) 2016-05-05
TW201507749A (zh) 2015-03-01
RU2015142824A (ru) 2017-04-17
KR20150126929A (ko) 2015-11-13
JP2016509895A (ja) 2016-04-04
US20160008550A1 (en) 2016-01-14
US10117998B2 (en) 2018-11-06
IL240547A0 (en) 2015-10-29
CN105025964A (zh) 2015-11-04
CN105025964B (zh) 2019-06-28
RU2015142824A3 (es) 2018-03-12

Similar Documents

Publication Publication Date Title
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
AR076722A1 (es) Conjunto para un dispositivo para l a entrega de farmacos y dispositivo para la entrega de farmacos
DOP2018000297A (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo
CL2009001055A1 (es) Dispositivo de suministro de medicacion que comprende; un mecanismo de dosificacion que comprende; un vastago de piston; un dispositivo aciionador; un miembro de ajuste de la dosis; un miembro de limitacion de la dosis; y una varcasa que aloja al menos parte del mecanismo de dosificacion.
CR20150628A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
AR095220A1 (es) Conjunto para un dispositivo de administración de fármacos
CL2016001874A1 (es) Forma de dosificación oral sólida de liberación modificada que comprende pridopidina y un excipiente de control de velocidad; formulación farmacéutica que comprende a la forma de dosificación; uso de la forma de dosificación o de la formulación farmacéutica para tratar una enfermedad neurodegenerativa o relacionada con dopamina, como la enfermedad de huntington, entre otras.
BR112015022972A2 (pt) composição farmacêutica de cloridrato de s-cetamina
AR093247A1 (es) Agente profilactico y/o terapeutico para sintomas conductuales y psicologicos asociados con la enfermedad neurodegenerativa o sintomas impulsivos asociados con enfermedad mental que contiene brexpiprazol o sales del mismo
BR112017021073A2 (pt) composições injetáveis de liberação prolongada compreendendo um agente ativo de isoxazolina, seus métodos e usos
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
CL2020000747A1 (es) Formulaciones de niraparib.
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
CL2015002543A1 (es) Derivado de dihidropiridazin-3,5-diona.
UY36460A (es) Pirazolpiridinaminas
CO2019008053A2 (es) Agente terapéutico para enfermedades del hígado
CL2015002466A1 (es) Formulaciones de compuestos orgánicos
MX2016006670A (es) Dispositivo de administracion de farmacos asistido por resorte.
AR095194A1 (es) Conjunto para un dispositivo de administración de fármacos
CO2020001887A2 (es) Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático
AR072795A1 (es) Una formulacion de fenofibrato, una capsula para administracion oral que comprende dicha formulacion y un proceso para la fabricacion de dicha formulacion
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
CL2014003326A1 (es) Formulación antioxidante inyectable de uso intravenoso de ascorbato de sodio - en altas dosis, y n-acetilcisteína como agentes oxidantes, y deferoxamina como agentes quelante de hierro, más excipientes farmacéuticos; método para su administración y uso en prevenir el daño por repertfusión en pacientes con inferto agudo del miocardío, sometidos a angioplastia caronaria primaria; y kit que la contiene.
ECSP16005679A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
CL2016003271A1 (es) Métodos para tratar infecciones

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee